Seth Basham has more than 18 years of experience covering retail stocks. Seth covered the hardline retail sector for five years at Credit Suisse and UBS, followed by five years investing in retail and consumer stocks on the buy side. Prior to business school, Seth was a strategy consultant.

Seth holds an MBA in Finance from Columbia Business School and a BA, Magna Cum Laude, with high honors in Economics from Colgate University. Seth is also a CFA charterholder.

Robert Driscoll, Ph.D., has over a decade in research and analytics in the life sciences sector – specifically in the area of oncology and more recently in the areas of infectious disease. He is a molecular biologist who received his Ph.D. from the University of Cambridge, and spent six additional years working in the lab at Stanford. He is particularly interested in the development and causes of cancer, as well as the expanding world of immuno-oncology. Since joining Wedbush in 2014, Robert has been covering a number of cutting-edge companies that include Srvinas (ARVN), Kura Oncology (KURA), Arcus Biosciences (RCUS), and IGM Biosciences (IGMS).

Robert received his Bachelor’s degree in Biochemistry from the University of Leeds, and his Ph.D. in Cellular and Molecular Biology from the University of Cambridge. He also completed a postdoctoral fellowship at Stanford University.